Hee Kang Selected Research

Asthma (Bronchial Asthma)

8/2007	Wheeze detection as a measure of bronchial challenge in young children with cough-variant asthma and with classic asthma.
12/2005	Maximal airway response to methacholine in cough-variant asthma: comparison with classic asthma and its relationship to peak expiratory flow variability.
6/2005	Bronchial responsiveness and serum eosinophil cationic protein levels in preschool children with recurrent wheezing.
5/2005	Bronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis.
2/2005	Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission.
9/2003	Bronchial hyperresponsiveness in adolescents with long-term asthma remission: importance of a Family history of bronchial hyperresponsiveness.
9/2003	Absence of association of peripheral blood eosinophilia or increased eosinophil cationic protein with bronchial hyperresponsiveness during asthma remission.
7/2003	Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis.
7/2003	Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hee Kang Research Topics

Disease

9	Asthma (Bronchial Asthma) 08/2007 - 07/2003
7	Neoplasms (Cancer) 01/2022 - 07/2012
5	Lymphedema (Milroy Disease) 01/2022 - 01/2017
4	Inflammation (Inflammations) 10/2023 - 02/2010
3	Hypersensitivity (Allergy) 06/2017 - 12/2005
3	Necrosis 11/2016 - 08/2010
2	Pain (Aches) 01/2022 - 12/2021
2	Bursitis (Adhesive Capsulitis) 01/2022 - 12/2021
2	Body Weight (Weight, Body) 01/2021 - 01/2015
2	Lung Neoplasms (Lung Cancer) 05/2020 - 01/2007
2	Obesity 01/2019 - 01/2015
2	Experimental Arthritis 11/2016 - 07/2008
2	Hemorrhage 07/2016 - 07/2012
2	Abscess 01/2016 - 04/2011
2	Common Cold 12/2011 - 02/2010
2	Arthritis (Polyarthritis) 12/2011 - 07/2008
2	Infections 04/2011 - 05/2009
2	Respiratory Sounds (Crackle) 08/2007 - 06/2005
2	Cough-Variant Asthma 08/2007 - 12/2005
2	Bronchiolitis 05/2005 - 07/2003
1	Endotoxemia 12/2022
1	Leukopenia 06/2022
1	Dysbiosis 06/2022
1	Arteriovenous Fistula 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Disease Progression 03/2021
1	Colitis 01/2021
1	Cholangiocarcinoma 11/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2020
1	Pancytopenia 09/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Insulin Resistance 01/2019
1	Peritonitis 12/2018
1	Spinal Stenosis (Stenosis, Spinal) 07/2016
1	Adenocarcinoma of Lung 10/2013
1	Septic Shock (Toxic Shock Syndrome) 03/2013
1	Malaria 05/2012
1	Neuroblastoma 05/2012
1	Lung Diseases (Lung Disease) 04/2012
1	Pharyngitis (Sore Throat) 04/2011
1	Cough 04/2011
1	Thromboembolism 03/2011

Drug/Important Bio-Agent (IBA)

5	Methacholine Chloride (Methacholine)FDA Link 08/2007 - 09/2003
4	Eosinophil Cationic ProteinIBA 06/2005 - 07/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 08/2010
3	LipopolysaccharidesIBA 11/2016 - 08/2010
3	Interleukin-6 (Interleukin 6)IBA 11/2016 - 08/2010
3	Biomarkers (Surrogate Marker)IBA 10/2013 - 05/2005
2	Gemcitabine FDA Link 06/2022 - 09/2019
2	PhytochemicalsIBA 01/2022 - 01/2019
2	sulfuretinIBA 01/2019 - 07/2017
2	OvalbuminIBA 06/2017 - 06/2009
2	Collagen Type II (Type II Collagen)IBA 11/2016 - 07/2008
2	CollagenIBA 11/2016 - 03/2011
2	CytokinesIBA 03/2013 - 07/2003
2	InterleukinsIBA 03/2013 - 05/2005
1	PolyphenolsIBA 10/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2022
1	Toll-Like Receptor AgonistsIBA 12/2022
1	Harmine (Telepathine)IBA 12/2022
1	paramylonIBA 06/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	ProcalcitoninIBA 03/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2020
1	buteinIBA 07/2020
1	Food Additives (Food Additive)IBA 12/2018
1	Class A Scavenger ReceptorsIBA 12/2018
1	Ethanol (Ethyl Alcohol)IBA 07/2017
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2017
1	Therapeutic UsesIBA 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Dinoprostone (PGE2)FDA Link 11/2016
1	AntibodiesIBA 11/2016
1	Tumor Biomarkers (Tumor Markers)IBA 11/2016
1	Hemostatics (Antihemorrhagics)IBA 01/2016
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2015
1	Blood Glucose (Blood Sugar)IBA 01/2015
1	Gallic AcidIBA 03/2013
1	syringic acidIBA 03/2013
1	Mefloquine (Lariam)FDA LinkGeneric 05/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2012
1	Epinephrine (Adrenaline)FDA LinkGeneric 03/2011
1	Protein Kinases (Protein Kinase)IBA 08/2010
1	NF-KappaB Inhibitor alphaIBA 08/2010
1	JNK Mitogen-Activated Protein KinasesIBA 08/2010

Therapy/Procedure

5	Oral Administration 06/2022 - 03/2011
5	Drug Therapy (Chemotherapy) 06/2022 - 07/2012
4	Therapeutics 01/2022 - 04/2012
2	Electroacupuncture 01/2022 - 12/2021
2	East Asian Traditional Medicine (Oriental Medicine) 11/2012 - 02/2010
2	Traditional Medicine (Folk Remedies) 12/2011 - 04/2011
1	Renal Dialysis (Hemodialysis) 05/2022
1	Time-to-Treatment 01/2022
1	Radiotherapy 01/2022
1	Subcutaneous Injections 01/2017
1	Decompression 07/2016
1	Precision Medicine 07/2012
1	Aftercare (After-Treatment) 04/2012
1	Intravenous Injections 03/2011